Retinopathy of prematurity: the disease process, classifications, screening, treatment, and outcomes.

Published

Journal Article (Review)

Retinopathy of prematurity (ROP) is the cessation of normal eye development and subsequent abnormal vessel growth that occurs exclusively in premature infants. ROP was first discovered in the 1940s and was for two decades the leading cause of blindness in children. Currently, the disease causes about 500 new cases of blindness per year. The severity of the disease increases with decreasing gestational age. The pathogenesis of ROP involves disruption of normal retinal vascularization. Vessel endothelial growth factor, insulin-like growth factor, and oxygen play important roles in its development. ROP is classified using an international classification system that provides direction for screening and treatment of premature infants. Examinations are performed by ophthalmologists, who identify the scope of vascularization, the degree of abnormal vessel growth, and the amount of the eye that is affected. Treatment modalities include cryosurgery and laser photocoagulation. Long-term outcomes include both structural and functional vision problems.

Full Text

Duke Authors

Cited Authors

  • Harrell, SN; Brandon, DH

Published Date

  • November 2007

Published In

Volume / Issue

  • 26 / 6

Start / End Page

  • 371 - 378

PubMed ID

  • 18069428

Pubmed Central ID

  • 18069428

Electronic International Standard Serial Number (EISSN)

  • 1539-2880

International Standard Serial Number (ISSN)

  • 0730-0832

Digital Object Identifier (DOI)

  • 10.1891/0730-0832.26.6.371

Language

  • eng